𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Monoamine metabolites in cerebrospinal fluid during treatment with clonidine or alprenolol

✍ Scribed by L. Bertilsson; K. Haglund; J. Östman; M. D. Rawlins; V. -A. Ringberger; F. Sjöqvist

Publisher
Springer
Year
1977
Tongue
English
Weight
318 KB
Volume
11
Category
Article
ISSN
0031-6970

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Monoamine metabolite levels in cerebrosp
Monoamine metabolite levels in cerebrospinal fluid of psychotic women treated with melperone or thiothixene
✍ Lars Bjerkenstedt; Bo Gullberg; Christer Härnryd; Göran Sedvall 📂 Article 📅 1977 🏛 Springer-Verlag 🌐 English ⚖ 693 KB

Psychotic women with schizophrenic symptoms were treated with melperone 100 mg X 3 (n = 29) or thiothixene 10 mg X 3 (N = 34) USING A DOUBLE-BLIND PROCEDURE. Before and during treatment, levels of HVA, MOPEG, and 5-HIAA, the major metabolites of DA, NE, and 5-HT, were determined in lumbar cerebrospi

Rhesus monkey cerebrospinal fluid amine
Rhesus monkey cerebrospinal fluid amine metabolite changes following treatment with the reversible monoamine oxidase type-A inhibitor cimoxatone
✍ Nancy A. Garrick; Timo Seppala; Markku Linnoila; Dennis L. Murphy 📂 Article 📅 1985 🏛 Springer 🌐 English ⚖ 671 KB

The effects of cimoxatone, a reversible inhibitor of monoamine oxidase type A (MAO-A), on the deaminated metabolites of norepinephrine, dopamine, and serotonin were examined in continuously collected rhesus monkey cerebrospinal fluid (CSF). Cimoxatone, 0.5-8 mg/kg given PO, produced dose-proportiona